A commercial T cell test found that age and time since infection are significant factors related to the magnitude of immune responses to COVID-19. In vaccinated individuals, only increasing age was associated with poor T cell responses, while time from vaccination or type of vaccine had no effect.
A new study found that teens' consumption of ultra-processed foods decreased significantly during the COVID-19 pandemic and continued to decline even after restrictions eased. This reversal took place due to changes brought by the pandemic, including school closures and working from home.
A new study found that women with obesity have suppressed ovarian follicle development and reduced production of reproductive hormones, which may underlie reduced fertility. The researchers also discovered that luteal phase defects are more prevalent in obese women during natural ovulatory cycles.
A new study presented at ENDO 2022 found that inactivated and mRNA COVID-19 vaccines do not cause significant fluctuations in thyroid function or increase the risk of emergency department visits among patients treated for hypothyroidism. The research suggests that these vaccines can be a safe option for this vulnerable population.
Researchers have made a breakthrough in controlling metamaterials with brainwaves, enabling real-time, remote, and wireless applications. The team developed a framework for remotely mind-controlled metasurfaces using Bluetooth technology.
A new ultra-low dose PET technique eliminates the need for a CT scan, significantly reducing patient radiation exposure. The technique uses background radiation to reconstruct attenuation maps and quantitative PET images, with an average organ quantitative error of 4.8-10 percent.
Researchers create an electromagnetic brain-computer-metasurface (EBCM) that can decode operator's intentions and send commands wirelessly. The system uses EEG signals to translate brain messages into various EM commands, enabling text communication between operators.
A novel somatostatin-receptor targeting peptide has shown excellent imaging in patients with meningiomas, identifying previously undetected lesions. The new agent offers significant logistical advantages, including a longer half-life and large-scale production capabilities.
A new study found a strong association between prediabetes and an increased risk of heart attacks, with patients having prediabetes being 25% more likely to experience a heart attack. The researchers also discovered that those with prediabetes were at higher odds for requiring percutaneous intervention and heart bypass surgery.
A new study suggests that probiotic bacteria, particularly Lactobacillus, may enhance the effectiveness of tamoxifen and other endocrine-targeted therapies in reducing ER+ breast cancer risk. The researchers found elevated levels of Lactobacillus in breast tissue of mice treated with tamoxifen, leading to decreased breast tumor formation.
A new study found that parabens increase the growth, invasion, and expression of genes linked to cancer in breast cancer cells from Black women. This effect was more pronounced in Black cell lines compared to white cell lines.
A novel targeted radionuclide alpha therapy, AC-NM600, has been shown to achieve significantly better outcomes than its corresponding beta therapy in treating metastatic castration-resistant prostate cancer. The study demonstrated slowed tumor growth and improved overall survival.
A new study by Vertice Pharma confirms that drinking coffee does not affect the absorption of a liquid formulation of levothyroxine. The research suggests that patients can take their medication with coffee without worrying about reduced absorption. This finding could lead to more flexibility in dosing and improved patient outcomes.
A Phase 3 study found fezolinetant to significantly reduce the frequency and severity of moderate-to-severe vasomotor symptoms associated with menopause. The treatment also improved sleep disturbances, supporting its use for treating moderate-to-severe hot flashes.
Researchers developed an AI model to analyze thyroid ultrasound images, identifying nodules unlikely to be cancerous with a sensitivity of 97%. This technology could reduce the number of unnecessary biopsies and assist radiologists in choosing which nodules should undergo biopsy.
Researchers evaluate Jumpcode Genomics CRISPRclean technology for transforming pandemic response through highly sensitive testing. The assay quickly identifies variant strain types and individual host responses in a single workflow.
Research found that patients using insulin have a higher risk of fractures compared to those using metformin, particularly in non-obese and well-controlled diabetic patients. Routine fracture risk assessments are recommended for these individuals.
A study using PET/CT revealed that residual COVID-19 symptoms can be attributed to ongoing lung inflammation. Treatment with steroids and antifibrotic drugs significantly decreased inflammatory activity.
Research finds prenatal exposure to BPA and DEHP may contribute to mood disorders later in life by altering brain chemistry. Adult offspring exposed to these chemicals displayed impaired fear responses and altered behavioral patterns, highlighting the importance of avoiding exposures during pregnancy.
A randomized controlled trial shows significant improvements in testosterone replacement therapy for men with poorly-controlled type 2 diabetes and hypogonadism. The treatment improved symptoms, libido, and quality of life, as well as delayed verbal recall, a potential early sign of dementia.
Two experimental male contraceptive pills, DMAU and 11β-MNTDC, have shown promising results in lowering testosterone levels without unacceptable side effects. The study found that 75% of men who took the active drug were willing to use it in the future, compared to 46.4% of those taking a placebo.
A study using PET imaging found that severe obstructive sleep apnea is associated with abnormal heart blood flow reserve, increasing the risk of heart disease. The findings suggest that cardiac PET imaging can identify high-risk OSA patients.
A study finds that adults with growth hormone deficiency (GHD) experience higher rates of endocrine and metabolic conditions, as well as cardiovascular disease. Daily somatropin injections improve quality of life, but treatment rates remain low.